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Abstract
Background: Transient receptor potential Vanilloid (TRPV) receptors are involved in nociception
and are expressed predominantly in sensory neurons. TRPV1, a non-selective cation channel has
been extensively studied and is responsible for inflammatory thermal hypersensitivity. In this study,
the expression and function of TRPV4 have been characterized and compared with those of
TRPV1.
Results: Immunohistochemical studies revealed that both TRPV1 and TRPV4 were co-expressed
in dorsal root ganglion (DRG) neuronal cell bodies and in the central terminals of laminae I and II
of the spinal dorsal horn (DH). In Ca2+  fluorescence imaging and whole-cell patch-clamp
experiments, TRPV1- and TRPV4-mediated responses were observed in a population of the same
DRG neurons. Sensitization of TRPV1 has been shown to be involved in inflammatory pain
conditions. Incubation with phorbol 12, 13-dibutyrate (PDBu), a PKC activator, resulted in a
significant potentiation of TRPV4 currents in DRG neurons. In TRPV4 expressing HEK 293T cells,
PDBu increased 4α-phorbol 12, 13-didecanoate (4α-PDD)-induced single-channel activity in cell-
attached patches, which was abrogated by bisindolylmaleimide (BIM), a selective PKC inhibitor.
TRPV4 is also expressed at the central terminals of sensory neurons. Activation of TRPV4 by 4α-
PDD increased the frequency of miniature excitatory post synaptic currents (mEPSCs) in DRG-DH
neuronal co-cultures. 4α-PDD-induced increase in the frequency of mEPSCs was further enhanced
by PDBu. The expression of TRP channels has been shown in other areas of the CNS; application
of 4α-PDD significantly increased the mEPSC frequency in cultured hippocampal neurons, which
was further potentiated by PDBu, whereas, TRPV1 agonist capsaicin did not modulate synaptic
transmission.
Conclusion: These results indicate that TRPV4 and TRPV1 are co-expressed in certain DRG
neurons and TRPV4 can be sensitized by PKC not only in DRG neuronal cell bodies, but also in the
central sensory and non-sensory nerve terminals. Co-expression of TRPV1 and TRPV4 ion
channels, their modulation of synaptic transmission and their sensitization by PKC may
synergistically play a role in nociception.
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Background
Transient receptor potential (TRP) channels are involved
in initiating and transmitting sensory information from
the periphery to the CNS. TRPV4 is a Ca2+ permeable non-
selective cation channel, first described as an osmosensor
[1] and recently has been shown to be activated by heat (>
27°C), low pH, phorbol ester derivative 4α-phorbol 12,
13-didecanoate (4α-PDD), endocannabinoids and ara-
chidonic acid (AA) metabolites [2-6]. It is expressed in
multiple tissues, including lung, kidney, heart, gut, sen-
sory neurons, sympathetic neurons, vascular smooth
muscle cells and endothelial cells [1,2,7-9]. The higher
expression levels of TRPV4 in keratinocytes indicate that
contribution of TRPV4 to thermal sensation is not
restricted to sensory neurons [10]. TRPV4 null mice dis-
played impaired osmotic regulation, suggesting that
TRPV4 is necessary for maintaining osmotic equilibrium
in mammals [11]. It has been reported that inflammatory
and thermal hyperalgesia induced by carrageenan is atten-
uated in TRPV4 knockout mice [12]. TRPV4 has been
shown to be required for hypotonicity-induced nocicep-
tion and chemotherapy-induced neuropathic pain
[13,14]. Furthermore, in models of painful peripheral
neuropathy induced by vincristine chemotherapy, alco-
holism and diabetes, mechanical hyperalgesia was attenu-
ated by intrathecal injection of TRPV4 antisense
oligodeoxynucleotides, and the similar effect was also
observed in TRPV4 knockout mice [15]. TRPV4 deficient
mice exhibited impaired acid- and pressure-induced noci-
ception [5]. TRPV4 has been shown to contribute to vis-
ceral hypersensitivity [16,17]. These studies suggest that
TRPV4 is involved in both inflammatory and neuropathic
pain and play a key role in mechanical nociception.
Vascular endothelial cells, renal collecting duct cells and
vascular smooth muscle cells expressing TRPV4 are partic-
ularly susceptible to cell swelling-induced Ca2+ influx that
can be blocked by ruthenium red, a nonspecific blocker of
TRP channels [4,7,18,19]. Cell swelling also activates
phospholipase A2 (PLA2) and produces AA. AA and its
cytochrome P450 metabolite 5',6'-epoxyeicosatrienoic
acids (EETs) activate TRPV4 [6]. Further evidence for this
pathway is shown by the ability of PLA2 blockers to
inhibit hypotonicity-induced Ca2+ influx and membrane
current [20]. In behavioral studies, hypotonicity-induced
nociception has been shown to involve PKA- and/or PKC-
mediated phosphorylation [21]. Modulation of TRPV1 by
PKC has been extensively studied; in this study, we will
address the modulation of 4α-PDD-induced TRPV4 func-
tion by PKC.
Activation of TRPV1 modulates synaptic transmission at
the first sensory synapse between DRG and DH neurons
[22-25]. TRPV1 has also been reported to modulate syn-
aptic transmission in certain regions of the brain [26-29].
The activation of TRPV4 facilitated substance P (SP) and
calcitonin gene related peptide (CGRP) release from the
central terminals of primary neurons in the spinal cord
[30]. Although it has been demonstrated that TRPV4 is
expressed in sensory and non-sensory neurons, the role of
TRPV4 in the modulation of synaptic transmission
remains to be studied.
In this study, we show that TRPV4 is co-expressed with
TRPV1 in DRG and dorsal horn laminae I and II. We have
also found that TRPV4-mediated channel activity induced
by 4α-PDD is further augmented by activation of PKC. In
addition, TRPV4 activation modulates synaptic transmis-
sion in DRG-DH co-cultures and hippocampal neuronal




Five weeks old Sprague-Dawley rats were anesthetized by
isoflurane and perfused with 4% paraformaldehyde. Sam-
ples of lumbar segments of the spinal cord and DRG were
harvested and quickly frozen. The spinal cord and DRG
were cut into 20 and 10 μm sections, respectively. The sec-
tions were incubated with polyclonal goat anti-TRPV1
antibody (Calbiochem, PC 420, 1:100) and rabbit anti-
TRPV4 antibody (Alomone, Israel, 1:100) for 2 hrs at
room temperature, then incubated with Rhodamine Red
™-X donkey anti-goat IgG (Jackson, 711-295-152, 1: 100)
and FITC donkey anti-rabbit IgG (Jackson, 715-095-151,
1: 100) for 1 hr at room temperature. Images were taken
by a confocal microscope.
DRG, DRG-DH and hippocampal neuronal cultures
DRG, DH and hippocampal neurons were isolated from
embryonic day 18 (E18) rat embryos, triturated and cul-
tured in Neurobasal medium (Invitrogen, Carlsbad, CA).
The adult DRG neurons were dissociated from 5 weeks
old rats. The serum-free medium was supplemented with
B-27 and glutamine (Gibco Invitrogen, Grand Island, NY)
and the neurons were plated on poly-D-lysine-coated
glass coverslips. The neurons were used after 2 weeks
growth in culture.
HEK 293T cell culture and transfection
Human embryonic kidney 293T cells were cultured in
DMEM with 10% fetal bovine serum and penicillin (50
units/ml)-streptomycin (25 μg/ml) (Gibco Invitrogen,
Grand Island, NY). TRPV4 cDNA and GFP cDNA were co-
transfected into HEK 293T cells with Lipofectamine 2000
reagent following manufacture's protocol (Invitrogen,
Carlsbad, CA). The fluorescent cells were used for record-
ing currents 24 hrs after transfection. The non-fluorescent
cells were used as a negative control.Molecular Pain 2009, 5:5 http://www.molecularpain.com/content/5/1/5
Page 3 of 13
(page number not for citation purposes)
Ca2+ fluorescence imaging
Adult dissociated rat DRG neurons plated on glass cover-
slips were incubated with 3 μM Fluo-4 AM (Invitrogen,
Eugene, OR) for 30 min at 37°C and washed with physi-
ological buffer containing the following (in mM): 140
NaCl, 5 HEPES, 2 CaCl2, 1 MgCl2, 2.5 KCl, 2 Lidocaine,
pH 7.35. Fluo-4 was excited at 488 nm, and emitted fluo-
rescence was filtered with a 535 ± 25 nm bandpass filter.
The ratio of the fluorescence change F/Fo was plotted to
represent the change in intracellular Ca2+ levels.
Whole-cell current recording
DRG neurons grown on poly-D-lysine-coated coverslips
were used for recording TRPV1 and TRPV4 currents. For
whole-cell patch-clamp recordings, the bath solution con-
tained (in mM): 140 Na gluconate, 5 KCl, 10 HEPES, 1
MgCl2, 1.5 EGTA, pH adjusted to 7.35 with NaOH and the
pipette solution contained (in mM): 140 K gluconate, 5
KCl, 10 HEPES, 2 MgCl2, 10 EGTA, 2 K2ATP, 0.5 GTP, pH
adjusted to 7.35 with KOH. Currents were recorded using
an Axopatch 200B integrating patch-clamp amplifier
(Axon Instruments Inc., Union City, CA). Data were digi-
tized (VR-10B; InstruTech, Great Neck, NY) and stored on
videotape. For analysis, data were filtered at 2.5 kHz (-3
dB frequency with an eight-pole low-pass Bessel filter;
LPF-8; Warner Instruments, Hamden, CT) and digitized at
5 kHz. Current amplitudes were measured using Channel
2 (software kindly provided by Michael Smith, Australian
National University, Canberra, Australia).
Single-channel current recording
The cell-attached patch-clamp technique was used to
record single-channel currents. The bath solution con-
tained (mM): K gluconate 140, KCl 2.5, MgCl2 1, HEPES
5, EGTA 1.5, pH adjusted with KOH to 7.3. The patch
pipettes were made from glass capillaries (Drummond,
Microcaps), coated with Sylgard (Dow Corning, Midland,
MI, USA). The patch pipettes were filled with a solution
that contained (mM): Na gluconate 140, MgCl2 2, HEPES
10, EGTA 1, pH adjusted with NaOH to 7.35. Currents
were recorded using an Axopatch 200B integrating patch-
clamp amplifier (Axon Instruments Inc., Union City, CA).
Data were digitized (VR-10B; InstruTech, Great Neck, NY)
and stored on videotape. For analysis, data were filtered at
10 kHz (-3 dB frequency with an eight-pole low-pass Bes-
sel filter; LPF-8; Warner Instruments, Hamden, CT) and
digitized at 50 kHz. The data were analyzed using Chan-
nel 2 and QUB (State University of New York at Buffalo,
NY)
Synaptic current recording
DRG, DH and hippocampal pyramidal neurons were
identified by their morphology. The extracellular bath
solution contained (in mM): 130 NaCl, 5 KCl, 1 MgCl2, 1
CaCl2, 10 HEPES, 5 D-glucose, pH 7.35 and the pipette
solution contained (in mM): 140 K gluconate, 2 MgCl2, 1
EGTA, 10 HEPES, 1 ATP, pH adjusted to 7.35 with KOH.
In order to record fast excitatory postsynaptic currents,
neurons were voltage-clamped (Axopatch 200B, Axon
Instruments Inc., Union City, CA) at -60 mV (close to ECl).
While recording mEPSCs the bath solution contained
lidocaine (10 mM). The data were filtered at 2.5 kHz and
digitized at 5 kHz. Data were analyzed using Mini Analy-
sis Program (Synaptosoft, Decatur, GA). The amplitude
and frequency of the events were determined from 30 s
data segments.
Chemicals and reagents
B27, glutamine, fetal bovine serum and penicillin-strepto-
mycin were obtained from Gibco Invitrogen, Grand
Island, NY. Fluo-4 AM was obtained from Invitrogen,
Eugene, OR. Lipofectamine 2000 reagent was obtained
from Invitrogen, Carlsbad, CA. All other chemicals used
in this study were obtained from Sigma (St. Louis, MO).
Data analysis
Data are represented as mean ± S. E. M. (Standard Error of
the Mean) Kolmogorov-Smirnov (KS) test was used to
compare the cumulative probability for inter-events and
amplitude between different groups. Student's t-test and
one way analysis of variance (ANOVA) were used for sta-
tistical comparisons and the significance is considered at
P < 0.05.
Results
Expression and co-expression of TRPV4 in DRG neurons
Using immunohistochemical, patch-clamp and Ca2+ fluo-
rescence imaging techniques, we studied the expression
and co-expression of TRPV4. Double immunostaining of
sections from whole DRG revealed that 33.7 ± 2.4% of
neurons expressed TRPV1, 88.5 ± 4.8% of the neurons
expressed TRPV4, and 27.9 ± 2.8% of the neurons
expressed both TPRV4 and TRPV1 (n = 4 rats, at least 3
slices from each animal) (Fig. 1A, B, C, D, E). The specifi-
city of antibodies has been confirmed by a single band in
Western blots from samples of HEK 293T cells heterolo-
gously expressing TRPV1 or TRPV4 (data not shown).
Similarly, in Ca2+ fluorescence imaging from adult disso-
ciated neurons, 37.6 ± 3.9% of neurons responded to cap-
saicin, 64.2 ± 5.4% of neurons responded to 4α-PDD and
29.5 ± 3.2% of neurons responded to both, which is con-
sistent with the immunostaining data (Fig. 1F). Mostly,
the co-expression of TRPV1 and TRPV4 was observed in
small and medium diameter neurons.
Then, we used whole-cell current recordings and deter-
mined whether TRPV1- and TRPV4-mediated currents can
be elicited in the same neuron. In embryonic rat DRG
neuronal cultures, 51/73 neurons responded to both cap-
saicin (100 nM) and 4α-PDD (10 μM) (Fig. 1G). TheseMolecular Pain 2009, 5:5 http://www.molecularpain.com/content/5/1/5
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results indicate that TRPV1 and TRPV4 are co-expressed in
DRG neurons. A higher number of neurons co-expressing
TRPV1 and TRPV4 in whole-cell current recording as com-
pared to immunostaining or Ca2+ fluorescence imaging
techniques may be due to the bias of selecting small diam-
eter neurons or differential expression of these two chan-
nels between embryonic and adult DRG neurons.
Modulation of TRPV4 by PKC
Several TRP channels have been shown to be modulated
by PKC, which contributes to inflammatory pain [31].
There are suggestions that TRPV4 may be modulated/acti-
vated by PKC [32,33]. In order to determine the modula-
tion of 4α-PDD-induced TRPV4 currents by PKC, we used
patch-clamp technique and recorded whole-cell and sin-
gle-channel currents.
In whole-cell current recordings, 4α-PDD (10 μM)-
induced current was robustly potentiated following incu-
bation with PDBu (1 μM, for 2 min), a PKC activator
(4.00 ± 0.65-fold, n = 11, P < 0.05, Fig. 2A, B). As a posi-
tive control, we determined the potentiation of TRPV1
currents by PKC. As expected, capsaicin-evoked TRPV1
currents were significantly potentiated by PDBu (2.37 ±
0.45-fold, n = 11, P < 0.05, Fig. 2A, C).
Then, we recorded single-channel currents in cell-attached
patches in DRG neurons and TRPV4 heterologously
expressed in HEK 293T cells. Single-channel currents were
recorded at positive and negative potentials. In DRG neu-
rons at a holding potential of +60 mV, single-channel cur-
rent had an amplitude of 4.40 ± 0.10 pA corresponding to
a chord conductance of 73.3 ± 1.6 pS and at -60 mV sin-
TRPV1 and TRPV4 are co-localized in dorsal root ganglion (DRG) neurons Figure 1
TRPV1 and TRPV4 are co-localized in dorsal root ganglion (DRG) neurons. A. Immunostaining of TRPV1 in DRG. 
B. Immunostaining of TRPV4 in DRG. C. Merged images of A and B. D. Expanded merged image. Bar = 50 μm. E. Summary 
graph showing the expression of TRPV1, TRPV4 and the extent of co-expression (n = 4). F. Ca2+ fluorescence imaging showing 
capsaicin- and 4α-PDD-induced responses in the same neurons. G. Whole-cell current trace showing capsaicin- and 4α-PDD-
mediated current responses in the same neuron.Molecular Pain 2009, 5:5 http://www.molecularpain.com/content/5/1/5
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gle-channel current had an amplitude of 1.76 ± 0.15 pA
corresponding to a chord conductance of 29.3 ± 2.5 pS (n
= 3, Fig. 3). In similar experimental conditions, single-
channel currents recorded at +60 mV from HEK cells had
an amplitude of 5.70 ± 0.04 pA corresponding to a chord
conductance of 95.0 ± 7.1 pS and at -60 mV had an ampli-
tude of 3.81 ± 0.04 pA corresponding to a chord conduct-
ance of 63.5 ± 6.3 pS (n = 5, Fig. 3). It is clear from these
experiments that TRPV4-mediated currents exhibited
strong outward rectification. The outward rectification
observed is similar to that observed with TRPV1 currents
and we have described that outward rectification is due to
both lower single-channel conductance and decreased
open probability (Po) at negative membrane potentials
[34]. In order to determine the mechanism of rectifica-
tion, we have constructed current-voltage relationship by
recording currents at different voltages form DRG neurons
and HEK cells expressing TRPV4. The data points of out-
ward and inward current limbs were fitted with linear
functions to determine the slope conductance. The cur-
rents recorded from DRG neurons exhibited slope con-
ductances of 135 ± 32 pS at positive potentials and 22 ± 4
pS at negative potentials (Fig. 3D). In similar experimen-
tal conditions, currents recorded from HEK cells express-
ing TRPV4 exhibited slope conductances of 110 ± 5 pS at
positive potentials and 76 ± 6 pS at negative potentials
Sensitization of TRPV4 and TRPV1 by PKC in cultured DRG neurons Figure 2
Sensitization of TRPV4 and TRPV1 by PKC in cultured DRG neurons. A. Both capsaicin (100 nM)-induced and 4α-
PDD (10 μM)-induced currents are potentiated by a PKC activator, PDBu (1 μM). B, C. Summary graphs showing potentiation 
of 4α-PDD- and capsaicin-induced current activity by PDBu (1 μM; n = 11). The asterisk (*) represents P < 0.05 as compared 
to control.Molecular Pain 2009, 5:5 http://www.molecularpain.com/content/5/1/5
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(Fig. 3B). These results show that TRPV4 channels exhibit
a strong outward rectification. The outward rectification
exhibited by TRPV4 channels recorded from DRG neu-
rons is more pronounced. The reason for this difference is
not known, but it is possible that associated proteins in
native TRPV4 channels [35] as reported in native TRPV1
channels [36] may contribute to rectification pattern.
In order to determine voltage dependency of the channel
activity, we analyzed single-channel open probability at
different membrane potentials from apparent single-
channel patches. Single-channel patches were confirmed
in patches that exhibited high Po by using the criteria of
non-overlapping events when the Po was > 0.7. The Po at
+60 mV and -60 mV is 0.84 ± 0.11 and 0.57 ± 0.11 (n = 3)
in DRG neurons and 0.14 ± 0.04 and 0.07 ± 0.03 (n = 4)
in HEK cells expressing TRPV4, respectively. These studies
suggest that TRPV4 exhibits a milder voltage dependency
in Po as compared to TRPV1.
In order to determine the role of PKC, cell-attached
patches were formed with the pipette containing 4α-PDD
(1 μM) and the cells were exposed to a PKC activator,
PDBu (1 μM). In cell-attached patches from TRPV4
expressing HEK 293T cells, single-channel activity
induced by 4α-PDD (1 μM) was significantly enhanced by
the incubation of the cells with PDBu (1 μM). The open
probability was significantly increased as compared to
patches, in which the cells were not incubated with PDBu
(control, 0.096 ± 0.023; PDBu, 0.507 ± 0.086; n = 7, P <
Current-voltage relationship of 4α-PDD-evoked single-channel current in TRPV4 transfected HEK 293T cells and in DRG neu- rons natively expressing TRPV4 Figure 3
Current-voltage relationship of 4α-PDD-evoked single-channel current in TRPV4 transfected HEK 293T cells 
and in DRG neurons natively expressing TRPV4. A. Single-channel currents induced by 4α-PDD recorded at different 
membrane potentials from transfected HEK 293T cells. B. Current-voltage relationship shows that single-channel conductance 
is lower at negative potentials (76 ± 6 pS) as compared to positive potentials (110 ± 5 pS). C. Single-channel currents induced 
by 4α-PDD recorded at different membrane potentials from DRG neurons. D. Current-voltage relationship shows that the 
single-channel conductance is lower than that of cloned TRPV4 at negative potentials (22 ± 4 pS) as compared to positive 
potentials (135 ± 32 pS). The single-channel conductance contributes to the macroscopic current rectification.Molecular Pain 2009, 5:5 http://www.molecularpain.com/content/5/1/5
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0.05, Fig. 4). In order to confirm the specificity of PKC
action, the cells were incubated with a selective PKC
inhibitor, BIM (500 nM). BIM significantly reduced the
increase in the Po induced by PDBu (PDBu, 0.476 ± 0.113;
BIM, 0.074 ± 0.035, n = 5, P < 0.05). These results indicate
that TRPV4 can be sensitized by activation of PKC.
Role of TRPV4 expressed in the central terminals of the 
spinal cord
Immunohistochemical data showed that TRPV1 and
TRPV4 are expressed not only in the DRG neuronal cell
bodies, but also expressed in central sensory nerve termi-
nals at laminae I and II of the spinal dorsal horn (Fig. 5).
In order to determine the role of TRPV4 expressed in the
spinal cord, we studied the modulation of synaptic trans-
mission by TRPV4 activation in DRG-DH neurons grown
in culture. In DRG-DH co-cultures, synaptic connections
are formed between DRG and DH neurons and synaptic
currents can be recorded by voltage clamping the DH neu-
rons. In a previous study from our lab has shown that
TRPV1 activation increases mEPSC frequency without
affecting the amplitude at the first sensory synapse [25].
We have also reported that only DRG-DH co-cultures
responded to capsaicin application by increasing the fre-
quency of mEPSCs. In similar experimental conditions,
application of capsaicin to DH-only cultures did not
induce a response suggesting the expression of TRPV1
only at the sensory nerve terminals. Application of 4α-
PDD (40 μM) increased the frequency of mEPSCs signifi-
cantly (2.33 ± 0.39-fold, n = 5, P < 0.05, Fig. 6), while
Enhancement of TRPV4-mediated single-channel current activity by PKC Figure 4
Enhancement of TRPV4-mediated single-channel current activity by PKC. A. Single-channel currents activated by 
4α-PDD (1 μM) recorded at + 60 mV from a cell-attached patch on TRPV4 transfected HEK 293T cells before and after PDBu 
incubation. The traces are shown at higher time resolution below and the amplitude histograms are shown on the right. B. 4α-
PDD-induced single-channel currents recorded at – 60 mV before and after PDBu incubation. The traces are shown at a higher 
time resolution below and the amplitude histograms are shown on the right.Molecular Pain 2009, 5:5 http://www.molecularpain.com/content/5/1/5
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there was no change in the amplitude of mEPSCs, suggest-
ing that TRPV4 activation causes enhanced glutamate
release from the presynaptic terminals. To determine
whether TRPV4-mediated increase in mEPSCs is modu-
lated by PKC, the neurons were incubated with PDBu (1
μM). A confounding issue is that PDBu by itself has been
shown to increase the mEPSC frequency by binding to a
site, independent of phosphorylation [25,37-40]; there-
fore, first we quantitated PDBu-mediated increase in the
frequency of mEPSCs. PDBu alone significantly increased
the frequency (2.58 ± 0.25-fold, n = 3, P < 0.05, Fig. 6).
However, application of 4α-PDD + PDBu synergistically
increased the frequency of TRPV4-induced mEPSCs (7.51
± 0.99-fold, n = 3, P < 0.05, Fig. 6). These results suggest
that TRPV4 activation modulates synaptic transmission,
which is further enhanced by activation of PKC.
Modulation of synaptic transmission by 4α-PDD in 
hippocampal neurons
TRP channels are also expressed in certain regions of the
CNS. TRPV1 and TRPV4 expression has been shown in the
hippocampus [29,41-43]. Rat embryonic cultured hip-
pocampal neurons were used to study the modulation of
synaptic transmission by activation of TRPV4. We have
selectively voltage-clamped hippocampal pyramidal neu-
rons identified by their morphology. Using whole-cell
recordings, application of 4α-PDD (10 μM) induced an
increase in the frequency of mEPSCs, which was not
accompanied by a change in the amplitude. The frequency
of mEPSCs was increased 2.40 ± 0.26-fold (n = 7, P < 0.05)
following application of 4α-PDD (Fig. 7). As observed in
DRG-DH cultures, application of 4α-PDD + PDBu syner-
gistically potentiated TRPV4-mediated response (10.06 ±
1.91-fold, n = 7, P < 0.05, Fig. 7). These experiments sug-
gest that TRPV4 activation exerts an effect presynaptically
and modulates synaptic transmission. Intriguingly, appli-
cation of capsaicin (1 μM) in voltage-clamped cultured
hippocampal pyramidal neurons neither changed the fre-
quency (1.11 ± 0.10-fold, n = 6) nor the amplitude of
mEPSCs. Although TRPV1 expression has been shown in
the hippocampus [41,42], the function has not been stud-
ied extensively. Recently, a form of long term depression
(LTD) has been attributed to activation of TRPV1 in the
hippocampus [29].
Discussion
TRPV1 has been extensively studied and has been shown
to be involved in inflammatory thermal hypersensitivity.
In this study, we have shown that: 1) TRPV1 and TRPV4
are co-expressed in a population of DRG neurons and
their terminals in spinal dorsal horn; 2) TRPV4 can be sen-
sitized by activation of PKC in DRG neurons similar to
that of TRPV1; 3) Activation of TRPV4 modulates synaptic
transmission at the first sensory synapse in the spinal
cord, which is enhanced by activation of PKC similar to
that of TRPV1; 4) TRPV4, but not TRPV1 activation mod-
TRPV1 and TRPV4 are expressed at the central terminals and are co-localized in spinal dorsal horn Figure 5
TRPV1 and TRPV4 are expressed at the central terminals and are co-localized in spinal dorsal horn. A. Immu-
nostaining of TRPV1 in dorsal horn. B. Immunostaining of TRPV4 in dorsal horn. C. Merged image showing the extent of co-
localization in yellow. Bar = 300 μm.Molecular Pain 2009, 5:5 http://www.molecularpain.com/content/5/1/5
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ulates synaptic transmission between hippocampal neu-
rons.
TRPV4 has been demonstrated to be activated by heat (>
27°C) and TRPV4-mediated Ca2+  influx is strongly
enhanced at 37°C in a PKC-dependent and -independent
manner [2,33]. PKC activation by phorbol ester deriva-
tives induced Ca2+ influx in HEK 293 cells transfected with
human TRPV4 cDNA and exposure to a hypotonic solu-
tion after phorbol myristate acetate incubation further
increased intracellular Ca2+ [32]. Furthermore, Alessandri-
Haber et al. reported that hypotonicity-induced Ca2+
influx was reduced by a PKCε inhibitor in DRG neurons
[21].
We have conducted experiments at room temperature to
avoid temperature effects and have studied whether 4α-
PDD-induced TRPV4 responses could be modulated by
activation of PKC. We have found that 4α-PDD-induced
TRPV4 channel activity is further potentiated by PKC in
whole-cell and single-channel recordings from DRG neu-
rons and HEK cells expressing TRPV4. The results suggest
Potentiation of 4α-PDD-induced changes in synaptic transmission by PDBu in DRG-DH co-cultures Figure 6
Potentiation of 4α-PDD-induced changes in synaptic transmission by PDBu in DRG-DH co-cultures. A. Applica-
tion of 4α-PDD (40 μM) increases the frequency of mEPSCs and this action is enhanced by incubation with PDBu (1 μM). Syn-
aptic currents are shown at a higher time resolution below. B. Cumulative probability plot indicates an increase in the 
frequency of synaptic events with 4α-PDD, which is further significantly enhanced following by PDBu incubation. C. The 
increase in frequency of events is not accompanied by a change in the amplitude. D. Summary graphs showing 4α-PDD-induced 
an increase in mEPSC frequency (n = 5) and potentiation by PDBu (n = 3). The asterisk (*) represents P < 0.05 as compared to 
control; (**) represents P < 0.05 as compared to 4α-PDD group.Molecular Pain 2009, 5:5 http://www.molecularpain.com/content/5/1/5
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that phosphorylation of TRPV4 by PKC is capable of sen-
sitizing this channel. Single-channel recordings show that
the potentiation is due to an increase in the open proba-
bility. Our study shows that a population of DRG neurons
co-expresses both TRPV1 and TRPV4. TRPV1 has been
implicated to contribute to inflammatory thermal and
chemical pain [44,45]. Given the finding that TRPV4 con-
tributes to mechanical hyperalgesia in behavioral tests
and TRPV1 is involved in inflammatory thermal hyperal-
gesia, expression of both of these channels in one neuron
will synergistically modulate nociception.
A hall-mark characteristic of many TRP channels is out-
ward rectification. We have shown that the outward recti-
fication observed with TRPV1 channels is due to both
reduced single-channel conductance and open probabil-
ity at negative potentials [34]. Single-channel TRPV4 cur-
rents recorded from DRG neurons showed more
pronounced outward rectification as compared to cur-
rents recorded from HEK cells. This may be due to associ-
ated channel protein such as PACSIN3 [35].
The synaptic transmission between DRG neurons and spi-
nal DH neurons play a key role in pain processing. Gluta-
mate is released from presynaptic terminal (the central
terminal of DRG neurons) upon a variety of stimuli and
binds to its postsynaptic receptors (NMDA and AMPA
receptors). Any process that increases glutamate release
(presynaptic effect) or augments AMPA and NMDA recep-
tor function (postsynaptic effect) may underlie central
sensitization. Application of 4α-PDD significantly
increased the frequency of mEPSCs without affecting the
Enhancement of 4α-PDD-induced increase in synaptic transmission by PDBu in cultured hippocampal neurons Figure 7
Enhancement of 4α-PDD-induced increase in synaptic transmission by PDBu in cultured hippocampal neurons. 
A. Application of 4α-PDD (10 μM) increases the frequency of mEPSCs, which is further potentiated by PDBu. The synaptic 
events are shown at a higher time resolution below. B. Cumulative probability plot shows a decrease in inter-event interval. C. 
The increase in frequency is not accompanied by a change in the amplitude. D. Summary graph showing 4α-PDD induces an 
increase in mEPSC frequency and this action is enhanced by PDBu (n = 7). The asterisk (*) represents P < 0.05 as compared to 
control; (**) represents P < 0.05 as compared to 4α-PDD group.Molecular Pain 2009, 5:5 http://www.molecularpain.com/content/5/1/5
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amplitude suggests that synaptic transmission is modu-
lated by a presynaptic locus of action. This is expected
because in the spinal cord TRPV4 is expressed only at the
central sensory nerve terminals. However, one could also
envision a postsynaptic effect by the release of neuropep-
tides such as CGRP, SP and bradykinin during intense syn-
aptic activity. It has been shown that activation of PKC by
PDBu or diacylglycerol (DAG) enhances excitatory synap-
tic transmission in the hippocampus [37-40]. Munc 13-1
is an essential priming factor in synaptic vesicles and it has
a DAG/PDBu binding C1 domain [40,46]. Munc 18-1 has
been shown to be essential for presynaptic vesicle release
and has been identified as a PKC substrate [47]. Activation
of Munc 13-1 or Munc 18-1 results in synaptic vesicle
release. These studies suggest that PDBu-induced potenti-
ation of synaptic transmission can be both PKC-depend-
ent and PKC-independent mechanisms [48]. Although
PDBu can modulate synaptic transmission by itself, we
observed that activation of TRPV4 and PKC, synergisti-
cally increased the frequency of mEPSCs as shown with
TRPV1 [25]. Therefore, enhanced expression and function
of TRPV4 will result in increased excitability of spinal dor-
sal horn neurons, which may contribute to central sensiti-
zation. In disease conditions such as diabetes, the
expression and function of TRPV1 is altered in spinal dor-
sal horn [49]. Similarly, TRPV4 expression and function
could be altered in disease conditions. The endogenous
ligand for TRPV4 may be EETs, generated from AA by cyto-
chrome P450 epoxygenase activation during cell swelling
[20]. It has been shown that intrathecal administration of
TRPV4 antisense oligonucleotides reduces mechanical
hyperalgesia [15]. However, it is not clear the locus of
action of the antisense oligonucleotides. Furthermore,
centrally acting TRPV1 antagonist has been shown to be
more effective [50], raising the possibility that antagoniz-
ing the central TRPs contributes to the overall analgesic
action. Therefore, targeting TRPV4 at the central terminals
may be a useful strategy to combat certain modalities of
pain.
TRP channels are expressed in different regions of the
brain. Both TRPV1 and TRPV4 are expressed in the hip-
pocampus [41,43,51]. TRPV1 activation has been
reported to be involved in augmentation of synaptic trans-
mission in the hypothalamus, locus coeruleus, nucleus
tractus solitarius, substantia nigra and spinal cord by the
observation that the mEPSC frequency was enhanced fol-
lowing application of capsaicin [22,23,25-28,52,53]. Fur-
thermore, in hippocampal interneurons, TRPV1
activation has been shown to mediate a form of LTD
involving interneurons, which is absent in TPRV1 knock-
out mice. LTD was induced by the TRPV1 agonists and
inhibited by TRPV1 antagonists [29]. TRPV1 knockout
mice show reduced anxiety-related behavior and deficits
in developing long-term potentiation [54]. In this study,
we show that activation of TRPV4, but not TRPV1, modu-
lates synaptic transmission in voltage-clamped cultured
pyramidal hippocampal neurons, suggesting that TRPV4
might play a role in CNS function. TRPV1-mediated mem-
brane currents in hippocampal neurons have not been
characterized fully. Therefore, lack of TRPV1-mediated
response in our experiments is possibly due to rapid
desensitization of TRPV1, selective expression in specific
neurons or ontogenic expression (embryonic vs. adult).
Future experiments conducted on specific cell types and
from embryonic vs. adult neurons may resolve this dis-
crepancy.
Conclusion
This study indicates that TRPV1 and TRPV4 are co-
expressed in certain DRG neurons and TRPV4 can be sen-
sitized by PKC not only in DRG neuronal cell bodies, but
also in the central sensory and non-sensory nerve termi-
nals. Co-expression of TRPV1 and TRPV4 ion channels,
their modulation of synaptic transmission and their sen-
sitization by PKC may synergistically play a role in nocic-
eption.
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